ERBB2 and gastric cancer: Among the mAbs currently used for Ab-based cancer immunotherapy, trastuzumab, a human epidermal growth factor receptor (HER2) inhibitor used for early-stage and metastatic HER2+ BC and GC treatment [131], compiles a long list of lncRNAs whose expression dysregulation seems to interfere with its action.